drug · protein
patient view →efgartigimod alfa
pre_registrationupdated 2mo agoby $ARGX ARGENX SE🔗 ChEMBL
community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 14 investigational indications.
targets
IgG receptor FcRn large subunit p51
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that